Chris Jacobs
Filing statistics
Whale profile Estimated
Percentile blend among members with a trade in the last 12 months: 50% disclosed volume, 30% largest trade, 20% trade count.
- 12-month volume
- $0
- 0 trades · midpoints
- Largest trade
- $250,001 - $500,000
- Median midpoint $8K
- All-time volume
- $6.3M
- 296 trades
- Late filings
- 85
- Filed after the STOCK Act deadline
- Hindsight 15% moves
- 20.7% · 37 of 296
- Stock moved 15%+ the trade's way within 30 trading days
- Avg 30-day forward return
- +1.1%
- Sign-adjusted: buys +, sells −
Volumes are range midpoints; forward returns use public closing prices after the disclosed trade date, so they are hindsight: they describe what the stock did, not what anyone could have known. Late filings are counted from official dates only. How this is calculated
Estimated portfolio Estimated
Portfolio values, holdings, returns, and allocations are estimates derived from disclosed dollar ranges and public market prices. They may differ materially from actual values. Not investment advice. How this is calculated
Top holdings Estimated
- Axsome Therapeutics, Inc.17.5%$194K
- Nordic American Tankers Limited9.8%$108.8K
- The Macerich Company8.2%$90.6K
- Viatris Inc.5.3%$58.9K
- F.N.B. Corporation4.8%$53.2K
- Northwest Bancshares, Inc.3.6%$39.6K
- Genco Shipping & Trading Limited3.5%$38.7K
- Kite Realty Group Trust3.3%$36.2K
- Sabra Health Care REIT, Inc.3.2%$35.1K
- First Horizon Corporation3.1%$34.1K
Sector allocation Estimated
- Healthcare30.5%$338.8K
- Financial Services23.5%$261K
- Real Estate21.3%$236K
- Energy20.1%$223.5K
- Industrials3.5%$38.7K
- Basic Materials1.1%$12.1K
- Consumer Defensive0.0%$67
Trades
Best buys after disclosure vs the S&P 500 Estimated
| Ticker | Asset | Type | Owner | Amount | vs S&P Estimated | Traded | Filed | Source |
|---|---|---|---|---|---|---|---|---|
| KOD | Kodiak Sciences Inc (KOD) | Buy | Self | $1,001 - $15,000 | +708.6% | Jul 18, 2022 | Sep 9, 202253d | Filing |
| KRYS | Krystal Biotech, Inc. (KRYS) | Buy | Self | $1,001 - $15,000 | +184.5% | Dec 12, 2022 | Jan 20, 202339d | Filing |
| AXSM | Axsome Therapeutics, Inc. (AXSM) | Buy | Self | $15,001 - $50,000 | +156.3% | Jun 16, 2022 | Jul 28, 202242d | Filing |
Worst buys after disclosure vs the S&P 500 Estimated
| Ticker | Asset | Type | Owner | Amount | vs S&P Estimated | Traded | Filed | Source |
|---|---|---|---|---|---|---|---|---|
| SRNE | Sorrento Therapeutics, Inc. (SRNE) | Buy | Self | $1,001 - $15,000 | -187.9% | Dec 28, 2020 | Feb 10, 202144d | Filing |
| AVXL | Anavex Life Sciences Corp. (AVXL) | Buy | Self | $1,001 - $15,000 | -177.3% | Oct 12, 2022 | Nov 16, 202235d | Filing |
| PLUG | Plug Power, Inc. (PLUG) | Buy | Self | $1,001 - $15,000 | -175.8% | Jul 18, 2022 | Sep 9, 202253d | Filing |
Totals: $3.5M bought and $2.8M sold (range midpoints); first trade Sep 8, 2020, last trade Dec 12, 2022. Stats computed Nov 6, 2026. Midpoints are 0.5 × (low + high) of the disclosed range.